Related Experiment Videos
Oxidized LDL and coronary heart disease
1Centre for Experimental Surgery and Anaesthesiology, University of Leuven, Belgium. paul.holvoet@med.kuleuven.ac.be
Acta Cardiologica
|November 9, 2004
Summary
Elevated oxidized LDL (low-density lipoprotein) is linked to coronary heart disease (CHD) risk. Metabolic syndrome components independently predict high oxidized LDL, which predicts myocardial infarction in the elderly.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Immunology
Background:
- Inflammation involves phospholipase A2 and myeloperoxidase catalyzing LDL oxidation.
- Oxidized LDL (oxLDL) results from lipid and protein oxidation, with aldehydes modifying apolipoprotein B-100.
- Oxidized LDL is associated with coronary heart disease (CHD).
Purpose of the Study:
- To investigate the prevalence and predictors of elevated oxidized LDL.
- To assess the association between oxidized LDL and cardiovascular risk factors and events.
Main Methods:
- Observational studies analyzing plasma oxidized LDL levels.
- Analysis of associations between oxidized LDL and CHD risk factors, including metabolic syndrome components.
- Prospective analysis of myocardial infarction prediction in the Health ABC cohort.
Main Results:
- Higher prevalence of elevated oxidized LDL in individuals with high calculated CHD risk prior to events compared to diagnosed CHD patients.
- Metabolic syndrome components (high triglycerides, low HDL-cholesterol, glucose intolerance, diabetes) independently predicted high oxidized LDL.
- Elevated oxidized LDL predicted myocardial infarction in well-functioning elderly individuals, independent of traditional risk factors and metabolic syndrome.
Conclusions:
- Oxidized LDL is a significant predictor of cardiovascular events, particularly myocardial infarction.
- Metabolic syndrome components are key independent predictors of elevated oxidized LDL.
- Statins may reduce oxidized LDL levels beyond their cholesterol-lowering effects.